SCHEMBL21292817

SCHEMBL21292817

O=C(NN=Cc1ccc([N+](=O)[O-])cc1)c1ccc(O)cc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.74
MAPT P10636 7/20 0.56
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
POLB P06746 6/20 0.56
IKBKB O14920 1/20 0.56
RAB9A P51151 3/20 0.56
GAA P10253 2/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
MGAM O43451 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
NPC1 O15118 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
RRM1 P23921 1/20 0.55
RRM2 P31350 1/20 0.55
RRM2B Q7LG56 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292815 1.00 PHGDH (0.74) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL21292765 0.87 PHGDH (0.70) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL21292762 0.87 PHGDH (0.70) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL20115428 0.87 MEN1 (0.63) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL21292852 0.87 MEN1 (0.63) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL29359751 0.85 PHGDH (1.00) PHGDHMAPTMEN1KMT2ALMNA
SCHEMBL21292676 0.85 PHGDH (1.00) PHGDHMAPTMEN1KMT2ALMNA
SCHEMBL14583880 0.85 PHGDH (1.00) PHGDHMAPTMEN1KMT2ALMNA
SCHEMBL21292818 0.82 KMT2A (0.58) PHGDHMAPTMEN1KMT2APOLB
SCHEMBL21292798 0.82 NPC1 (0.61) PHGDHMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885MEN1 2502/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885MEN1 2502/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885MEN1 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.